Report: More than half of the world's population will be overweight/obese by 2035

Published Date: 08 Mar 2023

The World Health Organization's 2023 Atlas predicts that 51% of the world's population, or more than 4 billion people, will be overweight or obese within the next 12 years.

Read Full News

Latest News

Pfizer, Innovent GLP-1 Drugs Clear China Insurance Hurdle

GLP-1 drugs from Pfizer and Innovent Biologics have passed a preliminary review to be potentially included in China's basic medical ⁠insurance drug catalogue.

A Year After Keto: Fat Loss Persists, Metabolism Recovers

In women with obesity, a very low-calorie ketogenic diet followed by structured refeeding can help maintain meaningful weight loss at 1 year while allowing the body’s energy expenditure to recover.

Hybio's Generic Weight-loss Drug Set for FDA Review

The U.S. Food and Drug Administration has agreed to review ⁠Chinese generics drugmaker Hybio Pharmaceutical's two experimental generic tirzepatide GLP-1s that, if approved,...

Food Noise: a Real Phenomenon Deserving of Being Treated

Emerging evidence shows that many people experience food noise, that it can be measured and, at least to some extent, treated with a GLP-1 or other strategy.

FDA Staff Question Peptides Backed by Kennedy Ahead Of Advisory Panel Review

U.S. FDA staff reviewers said there is little evidence to allow compounding pharmacies to manufacture seven popular peptides, in stark contrast to Health Secretary Robert F....

US FDA Greenlights Viridian's Thyroid Eye Disease Drug

The U.S. Food and Drug Administration has approved Viridian Therapeutics' drug to treat patients with thyroid eye disease, the ⁠company said on Friday.

Todays Updates

Asian Women With Breast Cancer Outlive White Peers

Researchers seek to understand why Asian women fare better with the disease.

FDA Approves Orca‑T, a Next‑Gen HSCT to Reduce GVHD

By carefully controlling the mix of stem and T cells, Orca‑T lowers the risk for graft-vs-host disease in adults with hematologic cancers.

Todays Updates

Asian Women With Breast Cancer Outlive White Peers

Researchers seek to understand why Asian women fare better with the disease.

FDA Approves Orca‑T, a Next‑Gen HSCT to Reduce GVHD

By carefully controlling the mix of stem and T cells, Orca‑T lowers the risk for graft-vs-host disease in adults with hematologic cancers.

Latest News

GLP-1 drugs from Pfizer and Innovent Biologics have passed a preliminary review to be potentially included in China's basic medical ⁠insurance drug catalogue.

In women with obesity, a very low-calorie ketogenic diet followed by structured refeeding can help maintain meaningful weight loss at 1 year while allowing the body’s energy expenditure to recover.

The U.S. Food and Drug Administration has agreed to review ⁠Chinese generics drugmaker Hybio Pharmaceutical's two experimental generic tirzepatide GLP-1s that, if approved,...

Emerging evidence shows that many people experience food noise, that it can be measured and, at least to some extent, treated with a GLP-1 or other strategy.

U.S. FDA staff reviewers said there is little evidence to allow compounding pharmacies to manufacture seven popular peptides, in stark contrast to Health Secretary Robert F....

The U.S. Food and Drug Administration has approved Viridian Therapeutics' drug to treat patients with thyroid eye disease, the ⁠company said on Friday.

News All Time

Novo's Top US Exec Wants More Insurance Coverage for Weight-loss Drugs

Denmark's Novo Nordisk, the maker of weight-loss drug Wegovy, hopes insurance will cover more U.S. users of the medication and balance direct-to-consumer sales that have...

Two Studies Link GLP-1 Use to Lower Breast Cancer Risk

Two studies, including one involving more than 100,000 women, linked GLP-1 receptor agonists to reduced incidence of breast cancer.

Trump Pricing Policy Will Affect Obesity Drug Launch in Europe

Eli Lilly expects to launch its weight-loss pill in Europe and Britain in the second half of ⁠2026 or early 2027, with the drugmaker targeting the out-of-pocket telehealth market.

GLP-1 QOL Benefits Greatest for Those With Obesity Plus T2D

Patients with co-occurring obesity and T2D have more favorable QOL outcomes on GLP-1s than those with either condition alone or multiple comorbidities.

Mediterranean Diet May Reduce Postpartum Metabolic Risk

A Mediterranean-based nutritional intervention initiated at 8-12 gestational weeks is associated with a reduced risk for metabolic syndrome 6 years postpartum, a prospective follow-up study finds.

China Approval for Eli Lilly GLP-1 Pill to Come as Soon as 2026, Executive Says

Eli Lilly's orforglipron type-2 diabetes and obesity pill could launch in China as soon ⁠as later this year, an executive at the U.S. drugmaker told Reuters, as rival Novo...

Urogenital Infections Tied to SGLT2 Therapy Discontinuation

Patients with type 2 diabetes who start SGLT2 inhibitors and then develop a urinary or genital tract infection are more likely to discontinue treatment than matched patients without an infection.

Protein Source Key for Weight Loss After Menopause

Postmenopausal women are often encouraged to eat more protein, but a new study finds that protein source matters, with plant-based protein outperforming animal protein for weight loss.

What GLP-1s Are Teaching Us About Compulsive Behavior

As GLP-1 research moves deeper into the brain, scientists are asking whether these drugs can help explain why some urges become so hard to resist.

Fasting and Calorie Restriction Work via Different Pathways

In adults with obesity, both intermittent fasting and calorie restriction lead to significant weight loss but act through distinct behavioral pathways.

NHS Recommends First Drug to Delay Type 1 Diabetes

NICE has recommended teplizumab — the first medicine to delay type 1 diabetes onset — in what Diabetes UK calls ‘a new age of treatment.’

GLP-1s Tied to Reduced Opioid Use in Chronic Pancreatitis

Among patients with chronic pancreatitis, GLP‑1 treatment is associated with a lower likelihood of initiating long-term opioid therapy or developing opioid use disorder.

GLP-1 Era Demands a New Model of Obesity Care

Panelists at HLTH Europe 2026 say obesity care must shift to lifelong digital models and shed its stigma as a moral failing.

Erosive Hand OA Flags Fracture Risk in Postmenopausal Women

Erosive hand osteoarthritis is associated with an increased risk for incident osteoporotic fractures in postmenopausal women, a study finds.

Medicare to Cover New Osteoporosis Diagnostic Screening Test

Medicare coverage of a new osteoporosis screening tool may help to address the challenge of identifying and treating patients with osteoporosis by expanding access to screening.

10-Hour Eating Window Boosts Weight Loss in Obesity

10-hour time-restricted eating promotes greater weight loss and improved body composition in adults with obesity and without diabetes than standard dietary counseling alone.

Recommended News For You

Positive Trials; Malignancies Increasing in Younger Adults; Andre Braugher's Cancer Dx.

France Expands 2026 Vaccination Rules Amid Resurgence

Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL

MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC

Poor agreement between diagnostic tests for breast cancer-related lymphedema

For some patients with bladder cancer that has invaded the muscle, trimodality therapy is just as effective as radical cystectomy.

unhealthy sleeping habits and the risk of esophageal adenocarcinoma.

Recommended Articles For You

Tumor Microenvironment Targeting: Mechanisms, Clinical Implications, and Therapeutic Advances 

Strategic Deals and FDA Approvals Transforming U.S. Oncology Drug Development 

Respiratory Ramifications of Systemic Disease: A Comprehensive Review 

Exploring Innovative Solutions for Infantile Hemangioma Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma

2.

According to new studies, some cancer patients can safely forego radiation therapy.

3.

Second opinions don't significantly delay breast cancer treatment

4.

Pickleball program boosts health and wellness for cancer survivors, study finds

5.

'Full House' Star's Cancer; Fluoride Fears Go Mainstream; Florida Doctor Arrested

1.

Contemporary Frameworks in Oncology Across Clinical Settings

2.

Practical Concepts in Hematology and Patient Outcomes

3.

Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL

4.

Epigenetic Signatures for Multi-Cancer Screening

5.

Synovial Sarcoma of Female Urethra: Case Report and Literature Review

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Efficient Management of First line ALK-rearranged NSCLC

2.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II

3.

Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2

4.

Newer Immunotherapies for Myeloma- A Comprehensive Overview

5.

Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot